Page last updated: 2024-10-18

glycine and Sarcoma, Kaposi

glycine has been researched along with Sarcoma, Kaposi in 1 studies

Sarcoma, Kaposi: A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cook, GC1

Other Studies

1 other study available for glycine and Sarcoma, Kaposi

ArticleYear
Jejunal absorption rates of glucose, glycine and glycylglycine in Zambian African adults with malnutrition.
    The British journal of nutrition, 1974, Volume: 32, Issue:3

    Topics: Adult; Aged; Biopsy; Dipeptides; Female; gamma-Globulins; Glucose; Glycine; Glycylglycine; Humans; I

1974